48 results on '"de Laroche, Guy"'
Search Results
2. Radiotherapy of rectal cancer in elderly patients: Real-world data assessment in a decade
3. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial
4. Dépistage de la détresse psychologique chez les patientes en cours de traitement du cancer du sein
5. Personnes âgées et radiothérapie : une synthèse de la littérature
6. Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial
7. Cancers rares et nouvelles techniques de radiothérapie
8. Évaluation du dépistage des cancers de la femme et du dépistage après 75 ans dans le département de la Loire
9. Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey
10. Correction to: From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience
11. Prise en charge du cancer primitif du vagin chez la femme de plus de 70 ans : intérêt d’une association radiothérapie-curiethérapie
12. Hypofractionated radiation therapy for treatment of bladder carcinoma in patients aged 90 years and more: A new paradigm to be explored?
13. Évaluation des pratiques professionnelles : améliorer la prise en charge de la douleur liée au cancer en oncologie radiothérapie
14. Mise en place d'une étude pilote de sensibilisation au réentraînement à l'activité physique dans deux populations sélectionnées atteintes d'un cancer du sein
15. Radiothérapie du creux axillaire dans les cancers du sein : état des lieux
16. Correlation of dosimetric parameters obtained with the analytical anisotropic algorithm and toxicity of chest chemoradiation in lung carcinoma
17. From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience
18. Cancer du canal anal : état des lieux, enjeux en oncogériatrie et thérapies moléculaires ciblées
19. Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region
20. Plasminogen Activator Inhibitor Type 1 is the Most Significant of the Usual Tissue Prognostic Factors in Node-Negative Breast Ductal Adenocarcinoma Independent of Urokinase-Type Plasminogen Activator
21. Curative-Intended Treatment of Squamous Cell Anal Carcinoma in Elderly Adults
22. Persistence of Medical Change at Implementation of Clinical Guidelines on Medical Practice: A Controlled Study in a Cancer Network
23. A controlled "before-after" study in a cancer network evaluating the impact of a clinical guidelines program on medical practice.
24. Late toxicity and quality of life from GETUG-AFU 22 study.
25. Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07)
26. Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region
27. Early toxicity of a phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer (OLIGOPELVIS GETUG P07)
28. Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker
29. Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients
30. The acute toxicity results of the GETUG-AFU 22 study: A multicenter randomized phase II trial comparing the efficacy of a short hormone therapy in combination with radiotherapy to radiotherapy alone as a salvage treatment for patients with detectable PSA after radical prostatectomy.
31. Radiotherapy for gynecologic cancer in nonagenarian patients: a framework for new paradigms
32. Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity
33. Personnes âgées et radiothérapie : une synthèse de la littérature
34. Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation
35. OLIGOPELVIS – GETUG P07, a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer: Preplanned analysis of acute toxicity.
36. Translating Clinical Evidence-Based Medicine into the Real World: Single-Center Experience with Cabazitaxel in Metastatic Prostate Cancer Patients
37. Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment
38. Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for biological relapse (BR) after radical prostatectomy (RP): Results of the GETUG-AFU 16 phase III randomized trial—NCT00423475.
39. Prise en charge du cancer primitif du vagin chez la femme de plus de 70ans : intérêt d’une association radiothérapie-curiethérapie
40. Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region
41. L'ANSES : un des acteurs de la sécurité sanitaire de l'eau destinée à la consommation humaine en France
42. Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region
43. La prise de décision partagée dans la rencontre médecin-patient : évolution récente et état des lieux dans le cancer du sein en France
44. Costs and compliance with clinical practice guidelines: A pilot study for initial sarcoma treatment
45. Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment.
46. Epidemiological evaluation of concordancebetween initial diagnosis and central pathologyreview in a comprehensive and prospective seriesof sarcoma patients in the Rhone-Alpes region.
47. Volumetric modulated arc radiotherapy for limited osteosclerotic myeloma.
48. From DRG databases to an epidemiological observatory for colorectal cancer in a French small area oncology network.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.